Physician profile
Kenneth Allen Mitchell
NPI 1922096379
$87,103.30
in general payments reported to CMS, 2019-2025
25 companies · $8,059 in 2025
The $8,059 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21K · 2022: $30K · 2023: $20K · 2024: $8,176 · 2025: $8,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,065 · Travel and Lodging: $8,933 · Honoraria: $8,250 · Food and Beverage: $6,886 · Consulting Fee: $3,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,065.00 |
| Travel and Lodging | $8,933.43 |
| Honoraria | $8,250.00 |
| Food and Beverage | $6,885.60 |
| Consulting Fee | $3,280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $33,273.06 | 2021-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $29,813.23 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Tolmar Pharmaceuticals, INC. | $9,617.03 | 2021-2022 | |
| Endo USA, INC. | $6,338.38 | 2024-2025 | Xiaflex |
| Coloplast Corp | $4,406.22 | 2021-2025 | Virtue, Titan |
| Boston Scientific Corporation | $1,666.59 | 2021-2025 | General - Erectile Dysfunction, Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Myovant Sciences INC. | $370.81 | 2021-2022 | |
| Tolmar, INC. | $323.61 | 2025 | Eligard, Jatenzo |
| Halozyme INC | $262.60 | 2023 | |
| Axonics, INC. | $165.43 | 2021 | |
| Olympus America INC. | $123.19 | 2025 | Itind System |
| Valencia Technologies Corporation | $116.23 | 2024-2025 | Ecoin Device Kit |
| Palette Life Sciences, INC. | $99.49 | 2022 | |
| Amgen INC. | $86.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.07 | 2021-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $63.57 | 2022 | |
| Astellas Pharma US INC | $60.00 | 2021 | |
| Acerus Pharmaceuticals Corporation | $55.51 | 2022 | |
| Sumitomo Pharma America, INC. | $44.59 | 2023 | Orgovyx |
| Millicent US INC | $39.54 | 2024 | Intrarosa |
| Profound Medical Corp. | $30.16 | 2025 | Tulsa-Pro |
| Abbvie INC. | $29.83 | 2024 | |
| Merck Sharp & Dohme LLC | $28.97 | 2024 | Keytruda |
| Idorsia Pharmaceuticals US INC | $13.51 | 2024 | Quviviq |
| Dendreon Pharmaceuticals LLC | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.